Scribe Therapeutics, Inc.
SCTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001853921
In the last 90 days, Scribe Therapeutics, Inc. insiders filed 5 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Superinvestors holding SCTX, Q2 2026
No superinvestor reported holding SCTX in Q2 2026.